Ștefan Gabriel, Podgoreanu Eugen, Mircescu Gabriel
Romanian Renal Registry, "Dr. Carol Davila" Teaching Hospital of Nephrology, Bucharest, Romania.
University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Ren Fail. 2025 Dec;47(1):2514830. doi: 10.1080/0886022X.2025.2514830. Epub 2025 Jun 12.
Vascular access type significantly influences outcomes in hemodialysis (HD) patients. Arteriovenous fistulas (AVFs) are preferred due to lower morbidity and mortality, while central venous catheters (CVCs) are associated with higher risks. This study, based on national registry data, examines vascular access patterns and their impact on mortality in Romanian HD patients.
A retrospective cohort analysis was conducted using Romanian Renal Registry data from patients initiating HD between 2020-2022, with follow-up until December 31, 2023. Vascular access was categorized as AVF, temporary CVC, or tunneled CVC. Survival analysis employed Kaplan-Meier curves and Cox proportional hazards models to evaluate the impact of vascular access type on mortality.
Among 6,863 incident HD patients, 20% initiated HD with an AVF, while 55% used temporary CVCs and 25% tunneled CVCs. AVF use increased to 53% in prevalent patients. Patients starting HD with AVFs had significantly better survival (39.1 months) compared to temporary (32.5 months) and tunneled CVCs (33.9 months). Mortality risk was over twofold higher in patients with CVCs at initiation. Transitioning from a CVC to an AVF significantly improved survival (HR 0.27, 95% CI 0.23-0.31).
The high CVC use at HD initiation underscores the need for improved CKD diagnosis and pre-dialysis nephrology care in Romania. Early AVF placement or timely conversion from CVC to AVF significantly enhances survival. These findings support a patient-centered approach to vascular access, emphasizing tailored care and enhanced pre-dialysis planning to optimize outcomes.
血管通路类型对血液透析(HD)患者的治疗结果有显著影响。动静脉内瘘(AVF)因发病率和死亡率较低而更受青睐,而中心静脉导管(CVC)则与较高风险相关。本研究基于国家登记数据,调查罗马尼亚HD患者的血管通路模式及其对死亡率的影响。
使用罗马尼亚肾脏登记处的数据对2020年至2022年间开始进行HD治疗的患者进行回顾性队列分析,并随访至2023年12月31日。血管通路分为AVF、临时CVC或带隧道的CVC。生存分析采用Kaplan-Meier曲线和Cox比例风险模型来评估血管通路类型对死亡率的影响。
在6863例新发HD患者中,20%以AVF开始HD治疗,55%使用临时CVC,25%使用带隧道的CVC。在现患患者中,AVF的使用率增至53%。与使用临时CVC(32.5个月)和带隧道的CVC(33.9个月)的患者相比,以AVF开始HD治疗的患者生存期显著更长(39.1个月)。开始治疗时使用CVC的患者死亡风险高出两倍多。从CVC转换为AVF可显著提高生存率(风险比0.27,95%置信区间0.23 - 0.31)。
HD治疗开始时CVC的高使用率凸显了罗马尼亚改善慢性肾脏病诊断和透析前肾病护理的必要性。早期放置AVF或及时从CVC转换为AVF可显著提高生存率。这些发现支持以患者为中心的血管通路方法,强调个性化护理和加强透析前规划以优化治疗结果。